SARS–CoV-2 immuno-pathogenesis and potential for diverse vaccines and therapies: opportunities and challenges
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus
that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19) …
that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19) …
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
L Chitsike, P Duerksen-Hughes - Virology Journal, 2021 - Springer
The COVID-19 pandemic has put healthcare infrastructures and our social and economic
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
COVID-19: characteristics and therapeutics
R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …
December 2019 is still haunting the entire human race and has affected not only the …
COVID-19 at a glance: An up-to-date overview on variants, drug design and therapies
D Iacopetta, J Ceramella, A Catalano, C Saturnino… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Promise and challenges in the development of COVID-19 vaccines
W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …
unprecedented challenge to global public health system and biomedical community …
COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …
Understanding COVID-19 pandemic: molecular mechanisms and potential therapeutic strategies. An evidence-based review
R Hanna, S Dalvi, T Sălăgean, ID Pop… - Journal of …, 2021 - Taylor & Francis
Abstract Initially, the SARS-CoV-2 virus was considered as a pneumonia virus; however, a
series of peer reviewed medical papers published in the last eight months suggest that this …
series of peer reviewed medical papers published in the last eight months suggest that this …
Precision therapeutic targets for COVID-19
ZA Krumm, GM Lloyd, CP Francis, LH Nasif… - Virology journal, 2021 - Springer
Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …
COVID-19: a global challenge with old history, epidemiology and progress so far
Humans have witnessed three deadly pandemics so far in the twenty-first century which are
associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and …
associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and …
[HTML][HTML] Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
HI Shih, CJ Wu, YF Tu, CY Chi - Biomedical journal, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by a novel
coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in …
coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in …